Within the four target investment areas, Mérieux Développement selects companies whose project is a real challenge for health and nutrition and finances the development or marketing of products and services with high added value.
Molecular diagnostics, Point of Care / Rapid Tests, Sample preparation, Clinical and industrial microbiology, Clinically-validated biomarkers, Management & Data analysis.
Imaging platforms and agents, Minimally invasive surgical and interventional devices, Ophtalmologic products, Biomaterials, Patient management software.
Management of home care, Specialized care for chronic and genetic diseases, Remote patient monitoring
Anti-infective agents, vaccines and tools, Nutrigenic services, Clinically validated nutraceuticals.
Since 2010, Mérieux Développement has invested in 20 companies, ranging from start-ups to profitable established companies within the healthcare space.